License to produce Lutetium-177 for clinical trials
ANSTO is proud to announce that a license has been issued by the Therapeutic Goods Administration to produce Lutetium-177 (Lu-177) for use in clinical trials.
Showing 241 - 260 of 847 results
ANSTO is proud to announce that a license has been issued by the Therapeutic Goods Administration to produce Lutetium-177 (Lu-177) for use in clinical trials.
Scandium 47, a therapeutic radioisotope and potential theranostic, has been produced for the first time at ANSTO. Theranostics are used to both diagnose and treat disease.
On the 10th of October 2025, the Minister for Industry, Science and Technology provided his Statement of Expectations to ANSTO.
The celebration of the UN’s International Women’s Day 2023 has a theme that highlights the power of innovative IT to combat discrimination and the marginalisation of women globally.
Paper on redefinition of the kilogram receives international award
ANSTO participates in nuclear medicine congress
The Biosciences team undertakes the radiolabelling of chemical, biochemical. biological or material vector for the purpose of radiotracing in living systems.
ANSTO has signed a strategic agreement with the Australian National University and sets the relationship between the two organisations, who collaborate on important projects, such as the fusion energy project ITER and space research, well into the future.
Agreement extends Taiwan’s National Synchrotron Radiation Research Center’s operation of neutron scattering instrument at ANSTO
This instrument can measure reflectivity at air-solid or air-liquid interfaces.
Ultra small angle neutron scattering on Kookaburra is used to study the size and shape of objects of size 10 micrometres and below.
Environmental scientists at ANSTO have been undertaking research to gain a better understanding of the potential impact of contaminants on decommissioned offshore oil and gas infrastructure since 2017
Although Australia does not use nuclear energy for power needs, it does have the nuclear capabilities, knowledge, and expertise provided by ANSTO to ensure the national interest in nuclear matters is protected and advanced.
Read about an ANSTO scientist and their work to prepare for a school project or interview.
Just under 250 schools in Australia and one school in Malaysia will participate in a series of science-based competitions during to coincide with National Science Week in 2024.
Developed by ANSTO’s predecessor the Australian Atomic Energy Commission (known as the AAEC) in the late 1960s, the Technetium-99m Generator revolutionised nuclear medicine imaging in Australia by enabling imaging procedures to be performed not only in major capital cities but throughout regional and rural Australia.
With over 70 years of nuclear expertise, ANSTO offers expert education and training programs